India’s drug discovery & development startup ecosystem is undergoing a boom, driven by technological advancements, the rise in talent pool and governmental initiatives. India is historically famous for its dominance in the generic drug manufacturing but is gradually shifting from the generic to innovative drug discovery, leveraging the new fields such as artificial intelligence (AI), and data science. These technologies are changing the landscape by speeding up and making the drug development more efficient, while reducing costs, and setting the stage for precision medicine.... >>More
Akhil Ravi, CEO, Aurigene Pharmaceutical Services
By Shripad Joshi, President - India & South Asia, Revvity
Dr. Mahesh Bhalgat, Group CEO & MD, Veeda Clinical Research
Vinay Jain, Chief Operating Officer, Onelife Nutriscience
By Dr. Shirish Alurkar, Sr. Consultant- Medical Oncology, HCG Cancer Centre